ERBB2 and breast cancer: It has been previously reported that 5,7-dihydroxy-8-nitrochrysin blocks HER-2/neu expression by inhibiting the phosphorylation of Akt in HER-2/neu-overexpressing MDA-MB-453 breast cancer cells (5).